COMMONLY used cardiac drug nifedipine (Adalat and others), when used in high dose, was associated with more than double the risk of a cardiac arrest than any dose of amlodipine, Dutch and Danish researchers reported at the European Heart Rhythm Association Congress 2019.
More than 61,000 patients were involved in the research.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Mar 19
